.- BESTCOPY AVAILABLE -oyeH PE RECEIVED | TON COLCGY | iSE E S= o i 8r e B. iso prey Din Homany K.
refid# KzpMO2q7ZkXzy3vERzv0G6eQ8 pages
CorrpoorsrateOOcccaupations Medias 25M1CC7eo3nte4r2,3bB0uidiTngetgho2n0e-305 1733 068 Fax AR226-0473 3M 5a.t PChoytstiacgieanGrPolvanet(S19u7m8m-a19r9y1)Reports Regarding Medical Surveillance Program Following reports of the finding of organic fluorine in sera samples, a fluorocheical medical surveillance program began at 3M manufacturing facilities in the mid 1970s "The surveillance program has generally consisted of annual or biannual tests ofclinical chemistries, pulmonary function, blood counts and abiomoritoroffluorochemical + exposure.
refid# 85QOvdj1JYqJvkj57mQEgROrZ1 page
AR226-0535 ACUTE TOXICITY TO AQUATIC INVERTEBRATES (E.G..DAPHNIA) TEST SUBSTANCE Identity: aPlesrfolbuoeroroecfteyrlrseudltfoonaasteF,ludoirdoeaclkyylldiammemtohnyliaummmodneriiuvmatisvalet.; may [1- D1,e1c,a2m2i,n3,i3u4m,,4,N5-,d5e,c6y,l6-,N7,,N7,-8d,i8me8t-hhyelp-t,adsealctafwlituhoro-1- octanesulfonic acid (1:1), CAS # 251099-16-8] LR-e1m4a3r9k4s:referTrehdet3o Mbyprtohdeutcetsitolnablootrantuomrbyears was Lot P3025. 1.
refid# MvreO8107BJRO5BvjEO2QbZz11 pages
ARR26 _ 0L63 ACUTE TOXICITY TO FISH (FATHEAD MINNOW) TESTSUBSTA0N 000C 0000E 00 Identity: A mixture containing perfluorooctanesulfonate, which may also be referred to as PFOS, FC-85, or as a component of FC-803F. (1Octanesulfonic acid) (CAS # 2795-393).
refid# Yj5bjNKek1yvn3BM7exV90JvE6 pages
AR 226 -- 0873 ACUTE TOXICITY TO FISH (MUMMICHOG) IEsTsuBsTANCE 000000 Identity: ArefmeirxrteudrteocaosntPaiFnOiSng, pFeCr-f9l5u,oroorocatsanaescuolmfponoanteen,twohficFhC-m7a8y0Ba.lso(1b-e Octanesulfonic acid) (CAS # 2795-39-3).
refid# n9Kgzk8DN1LMzaeQebpN0D52a15 pages
CT+ ._ 'TWefAlSoHnINPGoTlOyNmeWrORDKiSvision coe .
refid# evMr1n7dmzDL3x3rp9NXN26GE1 page
" Al22t1682 com Soma tm nna 8500 FRAT Suoject Enron Moncgrapn reer Sp eno SOAR eerie Ssoeeewreenno Tetesra ctura05 EPA Reetgvenn nh an J r 5i am0aa sSne yT,Dnwdhoor n8rt.aee0eansoS1t1F0n8AS8sl9no1ntas7rSs4Pt8E0SOrtoewnyChS ursee A2p On0x.Seur sosn,20, e Re tRCSie Sans cot 1 cs deowen nr A, EaaAmseemodyeteteeaospuotase(Smrb4i9nAeIiY TteLShingbnSEAReSlar hSSo rS o r e ee ce tBgVVano edAtanB0EERiATmtT Ttma e a e e a rer ves OVAra aamsi e mEeEAe et oe m ie e T ai epamer sveenn rm eavei Tsoe J rm. re ------ re serge om----S_ H OP POS 908 000011 00076442 Since REEnon out - eSasiiaofnI iy T siamminIfgLeSItoeLdgutNaAerdTiamtAasrLy aamuE ainra)t S sStE tthhee ssSoanmaegTgoEaapnnifloJraneyetoueby eLI vadcaesE iL aI s ineYTL goss aeuasadchCipaPeeme oesmiTertsgatSgiLfnsnoye.maon.dSTaaoneTee SmAiTecumhmaesaccnrtaee.Tcnhl.aeastnaAdcnhsoiAavniryhedacvpeaellaslnonwwiinegn Sinsearnaene. sae RIi LEanEI ET TSe e TyouUhEaveRaae n dheanteorfhouanaieTenhnleilneavgtheeTalnvhtaatoafecn:h2sedea4cpmhrdviiiilmsaaccryuyeosusAifLvooeoncveuulslo,dfvoLS"iuihpknleacedtlanuBtpdeoepienbgcosaunpssrepidraiateoesncehnecuirng e o EE o y It ayToTtbuiThotEeleixcpionsgesthefo:fesciheicaJemoferatlhospeopusitaucdiioens.<0 sSfoiaronvon-en:omBSaiagiiihnntaealssy,NTeRsOcsAtaIagdTee-r-(ooaova,sidzoo:lse1r1m0a3cd7.M4nes11y2UsA duponc. com) : STHEoTirScYeerveaSMeawaannsnonbRauuyurany,T:iiXtnohorbeosere1BrHBaaadncilekeieyss::: CsiMhnaidriainMaLiugrliiRese:cuesi:oDraovbiJedosneN RFBuSPrioankmchaont SHESeR Taren top AsA otavyeo, knTLw,ManwaeteeaenhtavyfeorcoamnaaruiEenigwaeinTncigvenweaensadtterureocvoofee sinaieyCEmoGi.sntdasLitnofmauuscEthFAnloaatngdebreSheaeWdORtEo wLo waT ve deAcoa indeedThvIaSTiAiiLnnLkignAgGEETvahaaondaeeehrdweedaafkrno4y0moonntTheheafisosennev3SfuTasevuaiamtcvaorepnyroufcSaeeictlayheleodurf30itanttadri,angmsi.nednnoYce a ELYe a TIEEetLtLaEItEiEtno,gaSmVTaaaanvraacGoofroiftaco.cittnnge 13wSs.iieinziaiisnedtaeiaepapdhnyyiPonnueoetwphioensngtan,evede,ec4hhaftovueptlivucsoneeug.mlmdyioluBe sacri Stave Washburn <svAsNbumbeRVEzoncorp. com Sn 13/53/2001 12:36:38 MH t2o nmeirsuawsaalnssacesaow<cerraamliastceernstsunoscccoononcass co Space: AZ: LEA Pagaon 3 Cannot Newt Next ee 000022 0007644) JBSEE IilaT uR angLwahLte he pIrimarEye authore T ineHs fT SesterAandS HsocFalRSseEmEees jBhE eiable cn seramer iT I, and 12 Bat 50 fag ft Se esseniial for i 5S2rae L the suI erica E wich AR sauen S53 Aaf ATames aE nd T AenesL ie can acnend, Sob TTomTRRnI m,aTnIiHoInL TShoeEn srermaersr.: eressi tinsenns. sem) LETTERS eR eemSenUBeE ReEneaeAeTeIeacAeT SFoervaeastieodanbe y:Semznaecs: Pesiiy/AL/Sent on STSonOeesN?
refid# j5vdDDjGgQqzE4M9VXmOmBr93 pages
RECEIVED - OPPT NCIC aKAY 12 85 9: 10 FINAL REPORT PROTOCOL 418-028 ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 `WITH THE REPRODUCTION/DEVELOPMENTAL TOXICITY SCREENING TEST SPONSOR'S STUDY NUMBER: T-7706.1 FINALREPORTDATE:31 JULY2003 PROTOCOL 418-028- TOORXAILCI(TGYAVSATGUED)YCOOFMTB-I7N70E6DWRIETPHETAHTEED DOSE SRCERPEREONDIUNCGTITEOSNT/DEVELOPMENTAL TOXICITY SPONSOR'S STUDY NUMBER: T-7706.1 TABLE OF CONTENTS SUBJECT PAGE 1.
refid# RzL3OmJZgvaXQVxbw4jamq9V770 pages
Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 1 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Appendix G: Amendments and Deviations (Copies) Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 2 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 3 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 4 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 5 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 6 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 7 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 8 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 9 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 10 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 11 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 12 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________
refid# zQLMvB77a2k3vQoJ2mXD0ZjQa12 pages
0 @ .
refid# wKRz6REdJg6wXpL26wQzBOazQ62 pages
Toxicological Summary PFOS Dietary Chronic Pilot Reproductive Study: Northern Bobwhite Test Substance: Perfluorooctancsulfonate (PFOS) Structure: Test Remarks: METHODS h1e-pOtcatdaenceasfullufoornoi-cpaoctiads,si1u,m1,s2a,lt2,,3C34A.S4,H5,257.96,56-,319,-73,8.8.88Tw6ha.es9s%tteobtryesdLubuMsntdSaenr,caem"ibHsi-eaNnMwthRci,otneadnipdtoiewoldnesemraenn(td3aplMuraLnioatlyty#wsiass21td7e)ec,thenriTmqhiuenesedsatmopplee Method: ASTM Standard E1062-86and `Type: Dietary Reproduction FIFRA Subdivision E.
refid# bOv686Bobybvp8Z6xX6n5pdYo12 pages
StudyTide FC-143:TWoYEARORAL TOXIITY-ONCOSGTUEDNYICNIRATTYS PEER RevoFiOveanwes Authors Peter C.
refid# DD0wYKrK1BE3MNQDjE5aaXJ6d15 pages
AR226-1966 ^'"'?
refid# KRD2Ba4By8Gx6QrNn2zrGYxz03 pages
TestResults AR226-2130 !
refid# O31kaZ8MQVg026NRd9kZMEeKK234 pages
AR226-2188 ^y Debbie J Mulrooney 08/23/2001 09:53 AM ' To: cc: Subject Chris E Shoop/AE/DuPontQDuPont Question on Source Spreadsheet Chris, I noticed that on the revised spreadsheet you added a column showing the fraction of PM that is C8.
refid# Rpo7NooLwdK8zRron02rkK7j81 page